Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/28/19 → 06/21/23 |
Funding
- Genentech Incorporated: $15,250.00
INC Research LLC: Open-Label, Parallel-Group Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effgects of Orcrelizumab in Children and Adolescents with Relapsing-Remitting Multiple Sclerosis
- Coyle, Patricia (CoPI)
- Manganas, Louis (PI)
- McLinskey, Nancy (CoPI)
Project: Research